Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 380

1.

Outcomes of Bariatric Surgery in Patients with Multiple Sclerosis.

Burn S, Stone A, Strange S, Seip R, Tishler D, McLaughlin T, Papasavas P.

Am Surg. 2018 Mar 1;84(3):e104-e105. No abstract available.

PMID:
30401336
2.

Effect of superamphiphobic macrotextures on dynamics of viscous liquid droplets.

Raiyan A, Mclaughlin TS, Annavarapu RK, Sojoudi H.

Sci Rep. 2018 Oct 18;8(1):15344. doi: 10.1038/s41598-018-33656-9.

3.

Real-world efficacy: intravenous palonosetron three-drug regimen for chemotherapy-induced nausea and vomiting with highly emetogenic chemotherapy.

Schwartzberg LS, McLaughlin T, Geller RB, Gabrail NY, Marks SM.

J Comp Eff Res. 2018 Oct 11. doi: 10.2217/cer-2018-0089. [Epub ahead of print]

4.

p58IPK Is an Endogenous Neuroprotectant for Retinal Ganglion Cells.

McLaughlin T, Dhimal N, Li J, Wang JJ, Zhang SX.

Front Aging Neurosci. 2018 Sep 7;10:267. doi: 10.3389/fnagi.2018.00267. eCollection 2018.

5.

"Dopamine homeostasis" requires balanced polypharmacy: Issue with destructive, powerful dopamine agents to combat America's drug epidemic.

Blum K, Modestino EJ, Gondré-Lewis M, Downs BW, Baron D, Steinberg B, Siwicki D, Giordano J, McLaughlin T, Neary J, Hauser M, Fried L, Badgaiyan RD.

J Syst Integr Neurosci. 2017 Nov;3(6). doi: 10.15761/JSIN.1000183. Epub 2017 Nov 17.

6.

Hyaluronan levels are increased systemically in human type 2 but not type 1 diabetes independently of glycemic control.

Nagy N, Sunkari VG, Kaber G, Hasbun S, Lam DN, Speake C, Sanda S, McLaughlin TL, Wight TN, Long SR, Bollyky PL.

Matrix Biol. 2018 Sep 6. pii: S0945-053X(18)30309-3. doi: 10.1016/j.matbio.2018.09.003. [Epub ahead of print]

PMID:
30196101
7.

Metabolic markers, regional adiposity, and adipose cell size: relationship to insulin resistance in African-American as compared with Caucasian women.

Allister-Price C, Craig CM, Spielman D, Cushman SS, McLaughlin TL.

Int J Obes (Lond). 2018 Aug 20. doi: 10.1038/s41366-018-0191-1. [Epub ahead of print]

PMID:
30127463
8.

Note from the Editor.

McLaughlin T.

J Health Care Poor Underserved. 2018;29(3):viii. doi: 10.1353/hpu.2018.0062. No abstract available.

PMID:
30122666
9.

Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies.

Salehi M, Vella A, McLaughlin T, Patti ME.

J Clin Endocrinol Metab. 2018 Aug 1;103(8):2815-2826. doi: 10.1210/jc.2018-00528.

PMID:
30101281
10.

Glucotypes reveal new patterns of glucose dysregulation.

Hall H, Perelman D, Breschi A, Limcaoco P, Kellogg R, McLaughlin T, Snyder M.

PLoS Biol. 2018 Jul 24;16(7):e2005143. doi: 10.1371/journal.pbio.2005143. eCollection 2018 Jul.

11.

Insurance Companies Fighting the Peer Review Empire without any Validity: the Case for Addiction and Pain Modalities in the face of an American Drug Epidemic.

Blum K, Jacobs W, Modestino EJ, DiNubile N, Baron D, McLaughlin T, Siwicki D, Elman I, Moran M, Braverman ER, Thanos PK, Badgaiyan RD.

SEJ Surg Pain. 2018 Oct 4;1(1):1-11.

12.

Molecular Chaperone ERp29: A Potential Target for Cellular Protection in Retinal and Neurodegenerative Diseases.

McLaughlin T, Falkowski M, Wang JJ, Zhang SX.

Adv Exp Med Biol. 2018;1074:421-427. doi: 10.1007/978-3-319-75402-4_52.

13.

Safety and efficacy of pasireotide in dumping syndrome-results from a phase 2, multicentre study.

Tack J, Aberle J, Arts J, Laville M, Oppert JM, Bender G, Bhoyrul S, McLaughlin T, Yoshikawa T, Vella A, Zhou J, Passos VQ, O'Connell P, Van Beek AP.

Aliment Pharmacol Ther. 2018 Jun;47(12):1661-1672. doi: 10.1111/apt.14664. Epub 2018 Apr 25.

PMID:
29696671
14.

Loss of XBP1 accelerates age-related decline in retinal function and neurodegeneration.

McLaughlin T, Falkowski M, Park JW, Keegan S, Elliott M, Wang JJ, Zhang SX.

Mol Neurodegener. 2018 Apr 4;13(1):16. doi: 10.1186/s13024-018-0250-z.

15.

Outcomes of Bariatric Surgery in Patients with Multiple Sclerosis.

Burn S, Stone A, Strange S, Seip R, Tishler D, McLaughlin T, Papasavas P.

Am Surg. 2018 Mar 1;84(3):e104-105. No abstract available.

PMID:
29559037
16.

Improvement of long-term memory access with a pro-dopamine regulator in an elderly male: Are we targeting dopamine tone?

McLaughlin T, Han D, Nicholson J, Steinberg B, Blum K, Febo M, Braverman E, Li M, Fried L, Badgaiyan R.

J Syst Integr Neurosci. 2017 May;3(3). doi: 10.15761/JSIN.1000165. Epub 2017 Jun 17.

17.

Integrative Personal Omics Profiles during Periods of Weight Gain and Loss.

Piening BD, Zhou W, Contrepois K, Röst H, Gu Urban GJ, Mishra T, Hanson BM, Bautista EJ, Leopold S, Yeh CY, Spakowicz D, Banerjee I, Chen C, Kukurba K, Perelman D, Craig C, Colbert E, Salins D, Rego S, Lee S, Zhang C, Wheeler J, Sailani MR, Liang L, Abbott C, Gerstein M, Mardinoglu A, Smith U, Rubin DL, Pitteri S, Sodergren E, McLaughlin TL, Weinstock GM, Snyder MP.

Cell Syst. 2018 Feb 28;6(2):157-170.e8. doi: 10.1016/j.cels.2017.12.013. Epub 2018 Jan 17.

PMID:
29361466
18.

Pro-dopamine regulator, KB220Z, attenuates hoarding and shopping behavior in a female, diagnosed with SUD and ADHD.

McLaughlin T, Blum K, Steinberg B, Modestino EJ, Fried L, Baron D, Siwicki D, Braverman ER, Badgaiyan RD.

J Behav Addict. 2018 Mar 1;7(1):192-203. doi: 10.1556/2006.6.2017.081. Epub 2018 Jan 10.

19.

National Comprehensive Cancer Network® Favorable Intermediate Risk Prostate Cancer-Is Active Surveillance Appropriate?

Aghazadeh MA, Frankel J, Belanger M, McLaughlin T, Tortora J, Staff I, Wagner JR.

J Urol. 2018 May;199(5):1196-1201. doi: 10.1016/j.juro.2017.12.049. Epub 2017 Dec 26.

PMID:
29288120
20.

Critical Analysis of White House Anti-Drug Plan.

Blum K, Fried L, Madigan MA, Giordano J, Modestino EJ, Steinberg B, Baron D, DeLeon M, McLaughlin T, Hauser M, Badgaiyan RD.

Glob J Addict Rehabil Med. 2017 Apr;1(4). pii: 555568. Epub 2017 Apr 27. No abstract available.

21.

A Double-Blind, Randomized Trial on the Efficacy and Safety of Hyperbaric Oxygenation Therapy in the Preservation of Erectile Function after Radical Prostatectomy.

Chiles KA, Staff I, Johnson-Arbor K, Champagne A, McLaughlin T, Graydon RJ.

J Urol. 2018 Mar;199(3):805-811. doi: 10.1016/j.juro.2017.10.016. Epub 2017 Oct 13.

PMID:
29031768
22.

The DRD2 Taq1A A1 Allele May Magnify the Risk of Alzheimer's in Aging African-Americans.

Blum K, Badgaiyan RD, Dunston GM, Baron D, Modestino EJ, McLaughlin T, Steinberg B, Gold MS, Gondré-Lewis MC.

Mol Neurobiol. 2018 Jul;55(7):5526-5536. doi: 10.1007/s12035-017-0758-1. Epub 2017 Sep 30. Review.

PMID:
28965318
23.

Incidence of Clinically Significant Prostate Cancer After a Diagnosis of Atypical Small Acinar Proliferation, High-grade Prostatic Intraepithelial Neoplasia, or Benign Tissue.

Wiener S, Haddock P, Cusano J, Staff I, McLaughlin T, Wagner J.

Urology. 2017 Dec;110:161-165. doi: 10.1016/j.urology.2017.08.040. Epub 2017 Sep 6.

PMID:
28888752
24.

Examining young children's social competence using functional ability profiles.

McLaughlin TW, Snyder PA, Algina J.

Disabil Rehabil. 2017 Aug 13:1-11. doi: 10.1080/09638288.2017.1363823. [Epub ahead of print]

PMID:
28805090
25.

Efficacy and pharmacokinetics of subcutaneous exendin (9-39) in patients with post-bariatric hypoglycaemia.

Craig CM, Liu LF, Nguyen T, Price C, Bingham J, McLaughlin TL.

Diabetes Obes Metab. 2018 Feb;20(2):352-361. doi: 10.1111/dom.13078. Epub 2017 Sep 24.

PMID:
28776922
26.

Lyme and Dopaminergic Function: Hypothesizing Reduced Reward Deficiency Symptomatology by Regulating Dopamine Transmission.

Blum K, Modestino EJ, Febo M, Steinberg B, McLaughlin T, Fried L, Baron D, Siwicki D, Badgaiyan RD.

J Syst Integr Neurosci. 2017 May;3(3). doi: 10.15761/JSIN.1000163. Epub 2017 May 11.

27.

KB220Z™ a Pro-Dopamine Regulator Associated with the Protracted, Alleviation of Terrifying Lucid Dreams. Can We Infer Neuroplasticity-induced Changes in the Reward Circuit?

McLaughlin T, Febo M, Badgaiyan RD, Barh D, Dushaj K, Braverman ER, Li M, Madigan MA, Blum K.

J Reward Defic Syndr Addict Sci. 2016;2(1):3-13. doi: 10.17756/jrdsas.2016-022. Epub 2016 May 19.

28.

Adipose tissue macrophages impair preadipocyte differentiation in humans.

Liu LF, Craig CM, Tolentino LL, Choi O, Morton J, Rivas H, Cushman SW, Engleman EG, McLaughlin T.

PLoS One. 2017 Feb 2;12(2):e0170728. doi: 10.1371/journal.pone.0170728. eCollection 2017.

29.

Digital Health: Tracking Physiomes and Activity Using Wearable Biosensors Reveals Useful Health-Related Information.

Li X, Dunn J, Salins D, Zhou G, Zhou W, Schüssler-Fiorenza Rose SM, Perelman D, Colbert E, Runge R, Rego S, Sonecha R, Datta S, McLaughlin T, Snyder MP.

PLoS Biol. 2017 Jan 12;15(1):e2001402. doi: 10.1371/journal.pbio.2001402. eCollection 2017 Jan.

30.

Role of innate and adaptive immunity in obesity-associated metabolic disease.

McLaughlin T, Ackerman SE, Shen L, Engleman E.

J Clin Invest. 2017 Jan 3;127(1):5-13. doi: 10.1172/JCI88876. Epub 2017 Jan 3. Review.

31.

The Benefits of Genetic Addiction Risk Score (GARS) Testing in Substance Use Disorder (SUD).

Blum K, Modestino EJ, Gondre-Lewis M, Chapman EJ, Neary J, Siwicki D, Baron D, Hauser M, Smith DE, Roy AK, Thanos PK, Steinberg B, McLaughlin T, Fried L, Barh D, Dunston GA, Badgaiyan RD.

Int J Genom Data Min. 2018;2018(1). pii: 115. doi: 10.29014/IJGD-115.000015. Epub 2018 Jan 15.

32.

Hypothesizing Las Vegas and Sutherland Springs Mass Shooters Suffer from Reward Deficiency Syndrome: "Born Bad".

McLaughlin T, Blum K, Steinberg B, Siwicki D, Campione J, Badgaiyan RD, Braverman ER, Modestino EJ, Gondré-Lewis MC, Baron D, Mash DC, Giordano J, Thanos PK.

J Reward Defic Syndr Addict Sci. 2017;3(2):28-31. doi: 10.17756/jrdsas.2017-038. Epub 2017 Dec 30.

33.

Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).

Blum K, Febo M, Fried L, Li M, Dushaj K, Braverman ER, McLaughlin T, Steinberg B, Badgaiyan RD.

Subst Use Misuse. 2017 Mar 21;52(4):535-547. doi: 10.1080/10826084.2016.1244551. Epub 2016 Dec 29.

34.

Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia.

Craig CM, Liu LF, Deacon CF, Holst JJ, McLaughlin TL.

Diabetologia. 2017 Mar;60(3):531-540. doi: 10.1007/s00125-016-4179-x. Epub 2016 Dec 14.

35.

Substituting poly- and mono-unsaturated fat for dietary carbohydrate reduces hyperinsulinemia in women with polycystic ovary syndrome.

Perelman D, Coghlan N, Lamendola C, Carter S, Abbasi F, McLaughlin T.

Gynecol Endocrinol. 2017 Apr;33(4):324-327. doi: 10.1080/09513590.2016.1259407. Epub 2016 Dec 2.

PMID:
27910718
36.

A glucocorticoid- and diet-responsive pathway toggles adipocyte precursor cell activity in vivo.

Wong JC, Krueger KC, Costa MJ, Aggarwal A, Du H, McLaughlin TL, Feldman BJ.

Sci Signal. 2016 Oct 25;9(451):ra103.

PMID:
27811141
37.

Low-Resolution Electromagnetic Tomography (LORETA) of changed Brain Function Provoked by Pro-Dopamine Regulator (KB220z) in one Adult ADHD case.

Steinberg B, Blum K, McLaughlin T, Lubar J, Febo M, Braverman ER, Badgaiyan RD.

Open J Clin Med Case Rep. 2016;2(11). pii: 1121.

38.

Multilevel Provider-Based Sampling for Recruitment of Pregnant Women and Mother-Newborn Dyads.

McLaughlin TJ, Aupont O, Kozinetz CA, Hubble D, Moore-Simas TA, Davis D, Park C, Brenner R, Sepavich D, Felice M, Caviness C, Downs T, Selwyn BJ, Forman MR.

Pediatrics. 2016 Jun;137 Suppl 4:S248-57. doi: 10.1542/peds.2015-4410F.

39.

The National Children's Study: An Introduction and Historical Overview.

Hudak ML, Park CH, Annett RD, Hale DE, McGovern PM, McLaughlin TJ, Dole N, Kaar JL, Balsam MJ.

Pediatrics. 2016 Jun;137 Suppl 4:S213-8. doi: 10.1542/peds.2015-4410B.

40.

Adipose Cell Size and Regional Fat Deposition as Predictors of Metabolic Response to Overfeeding in Insulin-Resistant and Insulin-Sensitive Humans.

McLaughlin T, Craig C, Liu LF, Perelman D, Allister C, Spielman D, Cushman SW.

Diabetes. 2016 May;65(5):1245-54. doi: 10.2337/db15-1213. Epub 2016 Feb 16.

41.

Impact of Starting an Emergency Medicine Residency Program on Overall Mortality Rate in a Regional Trauma Center.

McLaughlin T, Blow O, Herrick J, Richman P.

J Clin Med Res. 2016 Feb;8(2):84-9. doi: 10.14740/jocmr2410w. Epub 2015 Dec 28.

42.

Pasireotide induced adrenal insufficiency.

Weaver K, Craig C, McLaughlin T.

Clin Endocrinol (Oxf). 2016 Jun;84(6):946-7. doi: 10.1111/cen.13016. Epub 2016 Feb 8. No abstract available.

PMID:
26733356
43.

Neurobiology of KB220Z-Glutaminergic-Dopaminergic Optimization Complex [GDOC] as a Liquid Nano: Clinical Activation of Brain in a Highly Functional Clinician Improving Focus, Motivation and Overall Sensory Input Following Chronic Intake.

Duquette LL, Mattiace F, Blum K, Waite RL, Boland T, McLaughlin T, Dushaj K, Febo M, Badgaiyan RD.

Clin Med Rev Case Rep. 2016;3(5). pii: 104. doi: 10.23937/2378-3656/1410104. Epub 2016 May 11.

44.

The neuroprotective potential of endoplasmic reticulum chaperones.

McLaughlin T, Zhang SX.

Neural Regen Res. 2015 Aug;10(8):1211-3. doi: 10.4103/1673-5374.162696. No abstract available.

45.

Macro fat and micro fat: insulin sensitivity and gender dependent response of adipose tissue to isocaloric diet change.

Li Y, Gaillard JR, McLaughlin T, Sørensen TIa, Periwal V.

Adipocyte. 2015 Apr 21;4(4):256-63. doi: 10.1080/21623945.2015.1017153. eCollection 2015 Oct-Dec.

46.

Discovery of Triazole CYP11B2 Inhibitors with in Vivo Activity in Rhesus Monkeys.

Hoyt SB, Petrilli W, London C, Liang GB, Tata J, Hu Q, Yin L, van Koppen CJ, Hartmann RW, Struthers M, Wisniewski T, Ren N, Bopp C, Sok A, Cai TQ, Stribling S, Pai LY, Ma X, Metzger J, Verras A, McMasters D, Chen Q, Tung E, Tang W, Salituro G, Buist N, Clemas J, Zhou G, Gibson J, Maxwell CA, Lassman M, McLaughlin T, Castro-Perez J, Szeto D, Forrest G, Hajdu R, Rosenbach M, Xiong Y.

ACS Med Chem Lett. 2015 Jul 17;6(8):861-5. doi: 10.1021/acsmedchemlett.5b00048. eCollection 2015 Aug 13.

47.

Putative dopamine agonist (KB220Z) attenuates lucid nightmares in PTSD patients: role of enhanced brain reward functional connectivity and homeostasis redeeming joy.

McLaughlin T, Blum K, Oscar-Berman M, Febo M, Agan G, Fratantonio JL, Simpatico T, Gold MS.

J Behav Addict. 2015 Jun;4(2):106-15. doi: 10.1556/2006.4.2015.008.

48.

Using the Neuroadaptagen KB200z™ to Ameliorate Terrifying, Lucid Nightmares in RDS Patients: the Role of Enhanced, Brain-Reward, Functional Connectivity and Dopaminergic Homeostasis.

McLaughlin T, Blum K, Oscar-Berman M, Febo M, Demetrovics Z, Agan G, Fratantonio J, Gold MS.

J Reward Defic Syndr. 2015;1(1):24-35.

49.

Discovery of Benzimidazole CYP11B2 Inhibitors with in Vivo Activity in Rhesus Monkeys.

Hoyt SB, Park MK, London C, Xiong Y, Tata J, Bennett DJ, Cooke A, Cai J, Carswell E, Robinson J, MacLean J, Brown L, Belshaw S, Clarkson TR, Liu K, Liang GB, Struthers M, Cully D, Wisniewski T, Ren N, Bopp C, Sok A, Cai TQ, Stribling S, Pai LY, Ma X, Metzger J, Verras A, McMasters D, Chen Q, Tung E, Tang W, Salituro G, Buist N, Kuethe J, Rivera N, Clemas J, Zhou G, Gibson J, Maxwell CA, Lassman M, McLaughlin T, Castro-Perez J, Szeto D, Forrest G, Hajdu R, Rosenbach M, Ali A.

ACS Med Chem Lett. 2015 Apr 7;6(5):573-8. doi: 10.1021/acsmedchemlett.5b00054. eCollection 2015 May 14.

50.

The receptor CD44 is associated with systemic insulin resistance and proinflammatory macrophages in human adipose tissue.

Liu LF, Kodama K, Wei K, Tolentino LL, Choi O, Engleman EG, Butte AJ, McLaughlin T.

Diabetologia. 2015 Jul;58(7):1579-86. doi: 10.1007/s00125-015-3603-y. Epub 2015 May 9.

PMID:
25952479

Supplemental Content

Loading ...
Support Center